| 心力衰竭患者血浆可溶性晚期糖基化终末产物受体（sRAGE）变化与心功能的关系 |
| |
| 引用本文： | 郭新颖,郭彩霞,杜凤和,陈步星. 心力衰竭患者血浆可溶性晚期糖基化终末产物受体（sRAGE）变化与心功能的关系[J]. 首都医科大学学报, 2014, 0(6): 805-808 |
| |
| 作者姓名： | 郭新颖 郭彩霞 杜凤和 陈步星 |
| |
| 作者单位： | 1. 首都医科大学附属北京同仁医院心血管中心,北京,100730
2. 首都医科大学附属北京天坛医院心内科,北京,100050 |
| |
| 基金项目： | 国家自然科学基金，北京市科技新星计划基金(2010B050)。 This study was supported by National Natural Science Foundation of China，Sci-tech“New Star” Program of Beijing |
| |
| 摘 要： | 目的：探讨心力衰竭患者血浆可溶性晚期糖基化终末产物受体（soluble receptor for advanced glycation endproducts, RAGE）浓度变化,分析 sRAGE 与心功能的关系。方法选择首都医科大学附属北京同仁医院就诊的心力衰竭患者,纽约心脏学会（New York Heart Association,NYHA）心功能分级为Ⅱ~Ⅳ级,同期住院非心力衰竭患者为对照组,用酶联免疫吸附测定法方法定量检测血浆 sRAGE 浓度,对比分析各组间血浆 sRAGE 浓度的差异。结果血浆 sRAGE 浓度在对照组为（0.562±0.473）ng/mL,心力衰竭组为（0.844±0.705）ng/ mL,2组间比较差异有统计学意义（P〈0.01）。血浆 sRAGE 浓度在 NYHAⅡ级组为（0.680±0.506）ng/ mL、NYHAⅢ级组（0.844±0.646）ng/ mL、NYHAⅣ级组（91.077±0.910）ng/ mL。各组间比较差异有统计学意义（P〈0.05）。结论心力衰竭患者血浆 sRAGE 水平升高,且与心力衰竭的严重程度相关。
|
| 关 键 词： | 心力衰竭 可溶性晚期糖基化终末产物受体 严重程度 |
Relationship between plasma sRAGE and heart function in patients with heart failure |
| |
| Guo Xinying,Guo Caixia,Du Fenghe,Chen Buxing. Relationship between plasma sRAGE and heart function in patients with heart failure[J]. Journal of Capital Medical University, 2014, 0(6): 805-808 |
| |
| Authors: | Guo Xinying Guo Caixia Du Fenghe Chen Buxing |
| |
| Affiliation: | Guo Xinying, Guo Caixia, Du Fenghe, Chen Buxing ( 1. Cardiovascular Center, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China; 2. Department of Cardiology Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China) |
| |
| Abstract: | Objective To investigate the level of soluble receptor for advanced glycation endproducts（sRAGE） in patients with heart failure, to analyze the relationship between sRAGE and heart function. Methods Select 100 patients with heart failure treated in our hospital（NYHA Ⅱ-Ⅳ）, at the same time collect 50 cases hospitalized without heart failure, record general condition, and use the ELISA method to detect the levels of plasma sRAGE, applied SPSS 16. 0 software to carry on statistical analysis. Results The plasma sRAGE level was increased in patients with heart failure than the control group, showing a significant difference（P〈0. 01）. Plasma sRAGE level in the control group was（0. 562 ± 0. 473） ng/ mL, in the heart failure group was（0. 844 ± 0. 705） ng/ mL. With the cardiac function classification increased, plasma sRAGE level was elevated also, the control group was（0. 562±0. 473）ng/ mL, NYHAⅡ level group was （0. 680±0. 506）ng/ mL, NYHAⅢ level group was（0. 844 ±0. 646） ng/ mL, NYHAⅣ level was（1. 077 ±0. 910） ng/ mL. there is a significant difference （ P = 0. 004）. The plasma level of sRAGE had negative correlation with LVEF in patients with heart failure. Conclusion The plasma level of sRAGE was elevated in patients with heart failure, the level of plasma sRAGE and severity degree of heart failure present a associated relationship, with NYHA heart function classification increased, the plasma sRAGE level was elevated too. |
| |
| Keywords: | heart failure soluble receptor for advanced glycation endproducts severity level |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
